More articles from Review

  • Hepatocellular carcinoma: Options for diagnosing and managing a deadly disease
    Arvind R. Murali, MD, Carlos Romero-Marrero, MD, Federico Aucejo, MD and K.V. Narayanan Menon, MD
    Cleveland Clinic Journal of Medicine October 2013, 80 (10) 645-653; DOI: https://doi.org/10.3949/ccjm.80a.12163

    Because early diagnosis improves the chances of survival, it is important to identify patients who would benefit from surveillance.

  • Antisynthetase syndrome: Not just an inflammatory myopathy
    Soumya Chatterjee, MD, MS, FRCP, Richard Prayson, MD and Carol Farver, MD
    Cleveland Clinic Journal of Medicine October 2013, 80 (10) 655-666; DOI: https://doi.org/10.3949/ccjm.80a.12171

    With its variety of clinical presentations, it should be in the differential diagnosis for patients with unexplained interstitial lung disease.

  • Transient ischemic attack: Omen and opportunity
    Shruti Sonni, MD and David E. Thaler, MD, PhD
    Cleveland Clinic Journal of Medicine September 2013, 80 (9) 566-576; DOI: https://doi.org/10.3949/ccjm.80a.12141

    A transient ischemic attack (TIA) is often the precursor of stroke. As such, every TIA deserves to be taken seriously.

  • Biomarkers in the emergency workup of chest pain: Uses, limitations, and future
    Wassim Mosleh, HBSc, Husam Abdel-Qadir, MD and Michael Farkouh, MD, MSc
    Cleveland Clinic Journal of Medicine September 2013, 80 (9) 589-598; DOI: https://doi.org/10.3949/ccjm.80a.12112

    Cardiac biomarkers are only one piece of the clinical picture, albeit an important one.

  • Incidental ovarian cysts: When to reassure, when to reassess, when to refer
    Elisa K. Ross, MD and Medhi Kebria, MD
    Cleveland Clinic Journal of Medicine August 2013, 80 (8) 503-514; DOI: https://doi.org/10.3949/ccjm.80a.12155

    Most cysts are benign, but a few are malignant, with a notoriously poor survival rate. How can we tell if a patient truly needs surgery?

  • The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI
    The FREEDOM trial: In appropriate patients with diabetes and multivessel coronary artery disease, CABG beats PCI
    Bhuvnesh Aggarwal, MD, Sachin S. Goel, MD, Joseph F. Sabik, MD and Mehdi H. Shishehbor, DO, MPH, PhD
    Cleveland Clinic Journal of Medicine August 2013, 80 (8) 515-523; DOI: https://doi.org/10.3949/ccjm.80a.13030

    A large randomized trial finds bypass grafting superior to percutaneous intervention in a highly selected population.

  • Paget disease of bone: Diagnosis and drug therapy
    Paget disease of bone: Diagnosis and drug therapy
    Margaret Seton, MD
    Cleveland Clinic Journal of Medicine July 2013, 80 (7) 452-462; DOI: https://doi.org/10.3949/ccjm.80a.12142

    This focal disorder of aging bone may be asymptomatic or cause pain, bowing deformities, fractures, or nonspecific rheumatic complaints.

  • How to interpret surveys in medical research: A practical approach
    Colleen Y. Colbert, PhD, Enrique Diaz-Guzman, MD, John D. Myers, MD and Alejandro C. Arroliga, MD
    Cleveland Clinic Journal of Medicine July 2013, 80 (7) 423-435; DOI: https://doi.org/10.3949/ccjm.80a.12122

    Was the survey well designed? Was the sample appropriate and the response rate adequate? And do the data support the conclusions?

  • Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban
    Adewale Fawole, MD, Hamed A. Daw, MD and Mark A. Crowther, MD, MSC
    Cleveland Clinic Journal of Medicine July 2013, 80 (7) 443-451; DOI: https://doi.org/10.3949/ccjm.80a.13025

    How these new drugs work, what coagulation tests can tell us, and how to reverse the drugs’ anticoagulant effect.

  • Medication-assisted treatment of opiate dependence is gaining favor
    Jason M. Jerry, MD and Gregory B. Collins, MD
    Cleveland Clinic Journal of Medicine June 2013, 80 (6) 345-349; DOI: https://doi.org/10.3949/ccjm.80a.12181

    Recovering addicts are more likely to avoid returning to the use of opiates if they participate in a program that includes taking maintenance doses of methadone or buprenorphine.

Pages